Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

EMOLLIENT LOTION

Active
SPE2DP-26-T-4010Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Emollient Lotion is a non-sterile, homogeneous topical lotion formulated as either an oil-in-water or water-in-oil emulsion, packaged in 240 mL (8 fl oz) bottles with a dispenser cap. It must maintain a pH between 5.0 and 8.1 and contain a minimum of water, a suitable oil, an emulsifier, and a preservative, with additional ingredients such as stabilizers, thickeners, emollients, surfactants, humectants, colorants, and fragrances permitted in sufficient quantities. The product must exhibit a viscosity range of 10,000 to 20,000 CPS at 25°C when measured using a Brookfield Viscometer Model LVT with spindle No. 13 at 6 RPM. It is to be stored at controlled room temperature and shipped in compliance with the latest Medical Marking Standard No. 1 and DLA Packaging Requirements, including MIL-STD-129 labeling and ASTM D3951 commercial packaging unless classified as hazardous under Fed-Std-313, in which case IP025 requirements apply. The unit of issue is one bottle (BT), with a contract quantity of 500 bottles. Delivery is FOB destination, with a strict 20-day lead time and zero tolerance for quantity variance. The item is regulated by the FDA, and procurement requires an FDA referral via EBS including manufacturer and product details. The contract is issued under SPE2DP-26-T-4010 with NSN 6508-01-019-7181, and the delivery address is USS GEORGE WASHINGTON CVN 73, FPO AP 96607, with shipment coordinated per DLA procedures C19 and C20.

General Info

Procure 500 units of Emollient Lotion NSN 6508-01-019-7181 via DLA by July 13, 2026, open to all qualified contractors.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 100148 BOX 1, FPO, AP, 96607, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4010 Medical Supply Chain Pharm FSA

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

1 update
PhaseSolicitation
Posted

Solicitation

Amendment 1

Contract was updated

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Parris Sandlin
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
EMOLLIENT LOTION
EMOLLIENT LOTION
.
HOMOGENEOUS, NON-STERILE, BOTTLE W/DISPENSER CAP,
240 ML (8 FL OZ); PH RANGE BETWEEN 5.0 AND 8.1.
.
OIL IN WATER OR WATER IN OIL EMULSION. SHALL CONTAIN A
MINIMUM OF THE FOLLOWING INGREDIENTS IN SUFFICIENT QUANTITIES<(>,<)>
WATER<(>,<)> A SUITABLE OIL<(>,<)> EMULSIFIER AND A PRESERVATIVE; OTHER
INGREDIENTS SUCH AS EMULSION STABILIZERS<(>,<)> THICKENING AGENTS<(>,<)>
EMOLLIENTS<(>,<)> SURFACTANTS<(>,<)> HUMECTANTS<(>,<)> COLORING AGENTS
AND FRAGRANCES MAY BE ADDED IN SUFFICIENT QUANTITIES.
.
STORE AT CONTROLLED ROOM TEMPERATURE. HAS VISCOSITY
OF 10,000 CPS TO 20,000 CPS AT 25 DEG C PORM 2 DEG C USING A BROOKFIELD
VISCOMETER MODEL LVT (OR QUIVALENT) W/SPINDLE NO. 13 AND SPEED 6 RPM
.
UNIT OF ISSUE: BOTTLE (BT) OF 8 FL OZ
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. ..
AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC00096-0722-08
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4010
SECTION B
PR: 7017380652 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017380652 0001 BT 500.000
NSN/MATERIAL:6508010197181
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R21412
USS GEORGE WASHINGTON CVN 73
UNIT 100148 BOX 1
FPO AP 96607
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R21412
USS GEORGE WASHINGTON CVN 73
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
M/F: (TCN) R214126183P184
RDD: 777
PROJ: EP5 TP 2
SUPP ADD: YNMED SIG: A
SPE2DP-26-T-4010
SECTION B
PR: 7017380652 PRLI: 0001 CONT’D
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: 9B ADV: 2A FC: L7
Need Ship Date:00/00/0000 Original Required Delivery Date:07/08/2026
SPE2DP-26-T-4010 NSN/Part Number: 6508-01-019-7181 Quantity: 500 BT Purchase Request: 7017380652QTY: 500 Delivery: 20 days ADO

Similar Contracts

NAICS: 325412
New
DIBBS
APPLICATOR, SILVER NITRThe applicator contains a mixture of 75% silver nitrate and 25% potassium nitrate fused to one end, measuring 6 inches or 1.524 centimeters, and is intended for topical use only under prescription. Each container holds 100 applicators and must be stored in a closed package at room temperature in a dark, dry location, away from organic or oxidizable materials. This item is classified as a TYPE I (CODE M) with a non-extendable shelf life of 24 months and is regulated by the FDA, requiring confirmation via EBS referral by the contracting official. A current Material Safety Data Sheet (MSDS) must accompany each shipment and be submitted electronically to DLA.MSDS@DLA.MIL along with the required cover sheet, ensuring compliance with hazardous materials regulations including SPE2DP-26-T-4092, 49 CFR, and ICAO standards. Packaging must adhere strictly to hazardous material guidelines, and government identification must be removed from non-accepted supplies. The item is identified by NSN 6505-00-299-9672, procured under solicitation SPE2DP-26-T-4092 with a 20-day delivery requirement, and is governed by DLA’s Master List of Technical and Quality Requirements, with compliance based on the revision in effect at the solicitation or award date. The procurement is managed by the Department of Defense through the Medical Supply Chain Pharm FSA, with deliveries to Fort Stewart, Georgia, and primary point of contact Michelangelo Truscia.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
PRAZIQUANTEL TABLETSSix hundred milligram praziquantel tablets in blisters of six-count units are being procured under contract SPE2DP-26-T-4093, with a total quantity of eight blisters required for delivery within twenty days to Cannon AFB, New Mexico, FOB destination. Packaging must comply with commercial standards and the latest edition of Medical Marking Standard No. 1, superseding MIL-STD-129, ensuring each unit is sealed in protective containers and shipped in suitable exterior packaging that guarantees safe, cost-effective delivery via common carrier. The product is identified by NDC codes 50419-0747-01 and 49884-0231-83, and is designated as a TYPE I (CODE M) medical item with a non-extendable shelf life of twenty-four months. Mercury and mercury-containing compounds are strictly prohibited from direct or indirect contact with the product, except as explicitly allowed for specific functional components like batteries or instruments, which must meet Navy containment standards. All labeling and marking must adhere to Medical Marking Standard No. 1, and no government identification may be removed from non-accepted supplies. The acquisition is subject to the DLA Master List of Technical and Quality Requirements, with inspection and acceptance occurring at the point of delivery and no variance allowed in quantity. The item is to be delivered as a unit of issue, with pricing and logistics managed under DLA’s standardized procurement protocols.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
FLUORESCEIN SODIUMFluorescein Sodium Ophthalmic Strips, USP, are procured under contract SPE2DP-26-T-4089 with a total quantity of 2 packing groups, each containing 100 individually sealed 1 mg strips, for delivery to San Diego, CA within five days under FOB destination terms. The item is identified by NSN 6505-01-503-2390 and has a non-extendable shelf life of 36 months as a TYPE I (CODE Q) item. All packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and units must be sealed in protective containers that prevent damage during transit, shipped in commercial exterior containers at the lowest carrier rate. Labeling must include the NSN, manufacturer, CAGE code, date of manufacture, expiration or retest date, contract number, and lot number. The product is regulated by the FDA, and suppliers must submit approved Safety Data Sheets and Hazard Communication Standard-compliant labels per 29 C.F.R. 1910.1200, effective June 1, 2015, and ensure employee training on these requirements. Mercury or mercury-containing compounds are strictly prohibited except in specified functional components like batteries or instruments, and any such items must include a secondary containment boundary as outlined in NAVSEA 5100-003D. Only approved manufacturers including MEDLINE INDUSTRIES, LP, AMERISOURCEBERGEN DRUG CORP, and AMCON LABORATORIES, INC. with their designated NDC codes are qualified, and suppliers must provide documentation for FDA referral via EBS prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
ERYTHROMYCIN TABLETSThe contract pertains to the procurement of Erythromycin Base 250 mg tablets, packaged in units of 100 tablets per batch (BT), with a total quantity of one batch. The item is identified by NSN 6505-01-075-5095 and NDC codes 24338-0102-13 and 00093-5571-01, supplied by Teva Pharmaceuticals USA, Inc. All packaging must comply with commercial standards as specified in the procurement document, ensuring each unit is securely sealed to prevent damage or breakage, and shipped in exterior containers suitable for safe delivery by common carrier at the lowest rate to the destination. Packaging and marking must adhere to Medical Marking Standard No. 1, replacing all prior references to MIL-STD-129, and copies of this standard are available through DLA Troop Support or online. The item has a non-extendable shelf life of 36 months and is classified as a Type I (Code Q) item under shelf-life requirement RS001. Delivery is required FOB destination within 20 days, with no tolerance for variance in quantity, and inspection and acceptance occur at the point of delivery. The solicitation number is SPE2DP-26-T-4091, issued by the Department of Defense through the Medical Supply Chain PHARM FSA, with the point of performance at Dyess AFB, TX 79607-1367, and responses due by July 20, 2026. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the version in effect on the solicitation issue date controlling.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
Supplier of Human Albumin Medical ProductThe contract seeks a supplier to provide Human Albumin 5% solution in full compliance with military and medical standards, encompassing packaging, labeling, and delivery requirements essential for use in defense medical operations. The product must meet stringent quality and safety benchmarks to ensure it is suitable for field use and integration into military healthcare systems, with all components adhering to regulatory specifications for sterile pharmaceuticals distributed in high-stakes environments. The place of performance is designated as Nellis AFB with zip code 89191, indicating the primary delivery location for this critical medical supply. This subcontract opportunity, issued under NAICS code 325412 and managed by the Department of Defense through the Medical Supply Chain Pharm FSA, requires proposals to be submitted by the deadline of July 20, 2026, with the solicitation posted on July 13, 2026. The supplier must demonstrate the ability to reliably produce and transport the albumin solution under controlled conditions, ensuring product integrity from manufacture through final delivery. All packaging and labeling must comply with U.S. military protocols, including traceability, barcode compliance, and documentation to support inventory management in combat and emergency medical scenarios.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 6 days
View Details